Long-term safety and effectiveness of eptinezumab in patients with prior preventive migraine treatment failures

被引：0
|
作者：
Ashina, Messoud [1 ,2 ]
Tepper, Stewart J. [3 ]
Gendolla, Astrid [4 ]
Sperling, Bjorn [5 ]
Ettrup, Anders [5 ]
Josiassen, Mette Krog [5 ]
Starling, Amaal J. [6 ]
机构：
[1] Copenhagen Univ Hosp, Rigshosp, Danish Headache Ctr, Dept Neurol, Copenhagen, Denmark
[2] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[3] New England Inst Neurol & Headache, Stamford, CT USA
[4] Praxis Gendolla, Essen, Germany
[5] H Lundbeck & Co AS, Copenhagen, Denmark
[6] Mayo Clin Arizona, Scottsdale, AZ USA
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-DP-0
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [41] REAL-WORLD EFFECTIVENESS OF FREMANEZUMAB TREATMENT FOR REDUCING MONTHLY MIGRAINE AND HEADACHE DAYS IN US PATIENTS HAVING DIFFERENT NUMBERS OF PRIOR MIGRAINE PREVENTIVE TREATMENT FAILURES
    Cohen, J.
    Thompson, S.
    Sun, R.
    Driessen, M.
    Seminerio, M.
    Carr, K.
    Mu, F.
    VALUE IN HEALTH, 2022, 25 (01) : S30 - S30
  • [42] Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
    Oral, Elif A.
    Gorden, Phillip
    Cochran, Elaine
    Araujo-Vilar, David
    Savage, David B.
    Long, Alison
    Fine, Gregory
    Salinardi, Taylor
    Brown, Rebecca J.
    ENDOCRINE, 2019, 64 (03) : 500 - 511
  • [43] Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
    Rebecca J. Brown
    Elif A. Oral
    Elaine Cochran
    David Araújo-Vilar
    David B. Savage
    Alison Long
    Gregory Fine
    Taylor Salinardi
    Phillip Gorden
    Endocrine, 2018, 60 : 479 - 489
  • [44] Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
    Brown, Rebecca J.
    Oral, Elif A.
    Cochran, Elaine
    Araujo-Vilar, David
    Savage, David B.
    Long, Alison
    Fine, Gregory
    Salinardi, Taylor
    Gorden, Phillip
    ENDOCRINE, 2018, 60 (03) : 479 - 489
  • [45] Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
    Elif A. Oral
    Phillip Gorden
    Elaine Cochran
    David Araújo-Vilar
    David B. Savage
    Alison Long
    Gregory Fine
    Taylor Salinardi
    Rebecca J. Brown
    Endocrine, 2019, 64 : 500 - 511
  • [46] Long-term Efficacy of Erenumab in Patients With Episodic Migranie Who Have Failed Prior Preventive Migraine Therapies
    Reuter, Uwe
    Schwedt, Todd J.
    Kudrow, David
    Paemeleire, Koen
    Zhang, Feng
    Klatt, Jan
    Picard, Hernan
    Chou, Denise E.
    Mikol, Daniel D.
    NEUROLOGY, 2019, 92 (15)
  • [47] Eptinezumab demonstrated efficacy regardless of prior preventive migraine treatment failure: Post hoc DELIVER analyses
    Pozo-Rosich, Patricia
    Ashina, Messoud
    Tepper, Stewart J.
    Jensen, Sidsel
    Boserup, Line Pickering
    Josiassen, Mette Krog
    Sperling, Bjorn
    CEPHALALGIA, 2023, 43 (1supp) : 227 - 227
  • [48] Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine
    Ailani, Jessica
    Hutchinson, Susan
    Lipton, Richard B.
    Knievel, Kerry
    Yu, Sung Yun
    Finnegan, Michelle
    Severt, Lawrence
    Szegedi, Armin
    Trugman, Joel M.
    NEUROLOGY, 2019, 92 (15)
  • [49] Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
    Irimia, Pablo
    Santos-Lasaosa, Sonia
    Pozo-Rosich, Patricia
    Leira, Rogelio
    Pascual, Julio
    Lainez, Jose Miguel
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [50] Lack of "wearing off" effect with eptinezumab in the preventive treatment of migraine
    Cady, Roger
    Karnik-Henry, Meghana
    Asher, Divya
    Soni-Brahmbhatt, Seema
    Dodick, David W.
    NEUROLOGY, 2023, 100 (17)
12345